Abstract: The calcifying epithelial odontogenic tumor (CEOT) is a benign but locally-invasive odontogenic neoplasm believed to take origin from the stratum intermedium of the developing tooth germ. Bone morphogenetic proteins (BMPs) are multifunctional signaling molecules that regulate diverse cellular processes including epithelial-mesenchymal interactions during odontogenesis. Aberrant BMP activity has been enumerated in the ameloblastoma but information about its distribution in the CEOT remains limited. The aim here was to investigate BMP expression in CEOT and to speculate on its significance. Immunolabelling for BMP-2 and BMP-7 was performed on archival tissues of six CEOT cases and the level of expression was quantified as negative (0), mild (+), moderate (2+) and strong (3+). Results disclosed that CEOT epithelium demonstrated co-expression of BMP-2 and -7 suggesting upregulation of these proteins at sites of tumor differentiation. Distribution patterns were distinct with some overlap. Their localizations were largely membranous and/or cytoplasmic. Amyloid-like materials strongly expressed BMP-7 but were nonreactive for BMP-2, implicating that these signaling proteins play differential roles in the formation of these extracellular products. Mineralized substances including Liesegang rings were mostly negative for both BMPs suggesting that calcification process is associated with repression of these molecules. Stromal endothelium and fibroblasts were stained variably positive. BMP was heterogeneously detected in the CEOT epithelium at the tumor advancing front suggesting their upregulation at active sites and downregulation in quiescent areas. Present findings suggest that BMP-2 and BMP-7 most likely play differential roles in the cellular differentiation and progression of CEOT. BMP-7 accumulation within amyloid-like protein is a novel finding.
Introduction
The calcifying epithelial odontogenic tumor (CEOT) is a benign but locally-invasive odontogenic neoplasm that accounts for approximately 0.4-3% of all odontogenic neoplasms [1] [2] [3] [4] . It is unique for its tumoral growth pattern and the presence of amyloid materials that may become calcified 2) . The CEOT is believed to originate from remnants of the dental lamina or stratum intermedium of the developing tooth germ 3) . Clinically, CEOT has been reported in all age groups, peaking at age 40 years and shows an even sex distribution [2] [3] [4] [5] [6] . The mandible is more frequently involved than the maxilla, and the molar region is the site of predilection. Most CEOTs occur centrally in the jaws and appear as unilocular or multilocular radiolucencies with occasional radiopaque deposits or association with an unerupted tooth.
Peripheral variants are rare 1) . Microscopically, the tumor is characterized by presence of sheets, strands, or discrete islands of polyhedral epithelial cells supported by a fibrous connective tissue stroma [2] [3] [4] . These tumor cells have hyperchromatic and pleomorphic nuclei. Their cytoplasm is deeply eosinophilic with well-delineated borders and prominent intercellular bridges. A clear cell variant has also been reported 4) . A distinguishing feature of CEOT is the presence of amorphous and sometimes hyalinized extracellular eosinophilic material that stains positive for amyloid.
Calcifications are usually present. Noncalcifying CEOT is rare 4) .
Bone morphogenetic proteins (BMPs) were first identified by Marshall Urist in 1965 as proteins with an ability to induce bone or cartilage formation when implanted subcutaneously or intramuscularly in animals [5] [6] [7] . These polypeptides are secreted ligands that formed the largest subgroup within the transforming growth factor-â (TGFâ) superfamily 7) . There are 30 types of BMP and these are present in all tissues and organs. BMP-2 induces osteogenic differentiation whereas BMP-7 stimulates chondrogenic phenotype of adipose tissue-derived mesenchymal stem cells 6) . Recent evidence suggests that BMPs are multifunctional proteins involved in numerous cellular processes including proliferation, differentiation, chemotaxis and apoptosis of normal tissues during embryonic development and postnatally 8) .
BMP signaling is mediated via specific type I and type II serinethreonine kinase receptors (BMPR). Its ligand/receptor binding to type II receptor leads to oligomerization of the receptor complex, resulting in phosphorylation of the type I receptor and recruitment of downstream signaling protein namely Smad1, Smad5, and
It is known that BMPs especially BMP-2, -4 and -7 are involved in modulating epithelial-mesenchymal interactions during tooth development [9] [10] [11] . However reports of aberrant BMP activity in neoplastic odontogenic tissues remain conflicting [12] [13] [14] .
One study found positive BMP expression in benign cementoblastomas, dentinomas, odontogenic fibromas but was unable to demonstrate these proteins in ameloblastoma, adenomatoid odontogenic tumor and calcifying epithelial odontogenic tumor 12) . In contrast, another study observed that BMP-2, -4 and -7 were identified in all ameloblastoma subsets with BMP-7overexpression in the acanthomatous variant 13) . These .
Odontogenic tumors constitute a clinically significant group of jawbone neoplasms in the Asian region and are therefore a subject of considerable research [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Among the most well-studied are ameloblastomas [14] [15] [16] [17] [18] [19] , adenomatoid odontogenic tumor 15, 20) , keratocystic odontogenic tumor [21] [22] [23] and calcifying cystic odontogenic tumor [24] [25] . These works have enumerated the clinicopathologic characteristics and clarified the various signaling molecules implicated in the development of the various tumor entities [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] . Limited work has been published on Notch signaling proteins in the squamous odontogenic tumor 26) . Our current ongoing work focuses on the immunohistochemical characterization of key signaling protein molecules namely Notch in the CEOT 27) . Because of an earlier report 12) that negates the presence of BMP activity in the CEOT, this study was undertaken to examine independently whether indeed these proteins are absent in this neoplastic entity.
Materials and methods

Tissue samples
The test sample consisted of six CEOT cases that fulfilled the diagnostic criteria of the WHO classification of tumors 2) . All cases were intrabony lesions that demonstrated amyloid production and calcifications.This is a nonclinical study which was exempted from 
Immunohistochemistry
Immunostaining for BMP-2 and -7 was performed using the Envision technique as previously described 27) . Briefly, 
Immunohistochemical analysis
BMP distribution pattern and levels of staining intensity in all six CEOT cases were evaluated using descriptive and semiquantitative methods. In the latter, the immunostained sections were systematically sampled and the level of expression for BMP- when staining is present in extensive areas (>50%). Stromal immunoreactivity was also assessed in a similar manner.
Results
Microscopic findings
Histological examination revealed lesional tissues composed of sheets, strands and nests of polyhedral epithelial cells arranged in a pavementing pattern (Fig. 1A-C The tumor showed partial fibrous condensation resembling a capsule in some peripheral areas of the tumor while in others, have infiltrative features. On the basis of these histological findings, a diagnosis of CEOT was made.
Immunohistochemical findings
BMP-2 expression
BMP-2 protein distribution was detected in all six CEOT cases ( Fig.2A, 3A-D) . Positive staining was observed heterogeneously in the sheets, strands and islands of polyhedral epithelial cells (Fig. 3A) . Expression levels ranged from mildly focal to moderately strong and extensive (Fig. 3A) . Immunopositivity was mainly localized in the cytoplasm and/or cell membrane (Fig. 3B ).
Amyloid-like protein products were consistently negative for BMP-2 (Fig. 3C) . Calcified materials and Liesegang rings were nonreactive for BMP-2 (Fig. 5A ). Stromal vascular structures and fibroblasts stained weakly for this protein. Bone and its osteoblasts at the tumor advancing front were nonreactive for BMP-2 ( Fig.   3D ).
BMP-7 expression
All six CEOT cases demonstrated overexpression for BMP-7
in both the tumoral epithelium as well as the amyloid protein globules (Fig. 2B, Fig. 4A-D) . Protein localization was membranous and/or cytoplasmic. Vanable immunoreactivity for this molecule was observed in areas of calcifications (Fig. 4D,   Fig . 5B) and in Liesegang rings (Fig. 5B) . In the stromal endothelium and fibroblasts, BMP-7 was weak to barely detectable. At the bone infiltrating front, BMP-7 strongly stained CEOT tumoral epithelium but was mildly detected in the osteoblasts of the juxtaposed bone (Fig. 4B) . No osteoclastic activity was encountered.
Discussion
Mammalian BMP2-7 are members of the decapentaplegic-Vgrelated (DVR) gene family belonging to the TGF-β superfamily.
The aim of this study was to clarify the distribution of two members, BMP-2 and -7 in six cases of CEOT. Our immunohistochemical results revealed that these two proteins were co-expressed in the tumoral epithelium but differ with respect to their distribution in amyloid globules. These findings contrasted with those of Gao et al 12) who found that BMP was absent in their two cases of CEOT. Accordingly, BMP was not detected in CEOT because the tumor cells might be too immature to synthesize detectable BMP 12) . In view of these discrepancies in findings between published 12) and present study, examination of BMP activity in larger series of CEOT is warranted.
BMP-2 and -7 putatively play an important role in modulating epithelial-mesenchymal interaction necessary for induction of tooth formation. BMP-2 and -7 are present in the dental epithelium during the dental lamina, bud and cap stages 28) . However at bell stage, their expression patterns would shift from dental epithelium to the dental mesenchyme where BMP-2 is localized in differrentiated odontoblasts and BMP-7 to the dental mesenchyme [28] [29] [30] [31] . Current data revealed that BMP localization in the CEOT epithelium showed some similarities and differences with the expression patterns of these molecules in the developing dental epithelium during tooth morphogenesis [9] [10] [11] . Positive expression for BMP-2 and -7 in CEOT epithelium was comparable with the co-distribution of these proteins in the presumptive dental epithelium during the initiation stages (bud and cap) of tooth development [9] [10] [11] [28] [29] [30] [31] . From these observations, it might be possible that the CEOT epithelium arises from dental epithelium belonging to the earlier stage of cellular differentiation before lineage commitment.
The CEOT is a benign but locally-aggressive neoplasm with a tendency to invade bone. In this study, we also examined the CEOT-bone interface for BMP activity. We found that CEOT epithelium at the tumoral advancing front showed positive expression for both BMP-2 and -7, and that their expression levels were heterogeneous. This observation seems to suggest that those . However in this study we did not encounter any osteoclastic activity at the tumor advancing front in all six cases of CEOT evaluated and therefore is unable to verify this.
Amyloid is a fine nonbranching fibrillar protein with a cross â-pleated sheet structure. It is identifiable in tissues as pink amorphous substances that stained positively with Congo red to produce an apple-green birefringence under polarized light.
Amyloid deposits may be local or systemic. In the latter, the primary form commonly complicated plasma cell dyscrasia whereas secondary amyloidosis is a frequent outcome of chronic inflammatory processes 33) . CEOT is unique in that it synthesizes amyloid globules which are not native to the developing tooth primordium. In this study we demonstrated positive BMP-7 expression in these amyloid globules. BMP-2 was not detected.
The significance of this finding remains unknown. In other systemic diseases such as Alzheimer disease, BMP-6 accumulations surrounding diffuse and mature amyloid-β plaques purportedly have deleterious effects on neurogenesis 34) .
Calcifications and Leisegang rings in the CEOT were mostly nonreactive for both BMPs. The reason for this is not yet known but it may be related to the downregulation of these signaling molecules during the process of calcification. Gao et al 12) suggested that the mechanism of calcification is possibly different and independent of BMP signaling pathway.
This study also revealed that the expression patterns of BMPs in the CEOT are distinctive from other odontogenic epithelial neoplasm such as the ameloblastoma 14) . We speculated that these differences might be related to different functional activities of the BMP signaling molecules during the oncogenesis and cytodifferentiation of these tumor entities.
In summary, a study to investigate the distribution of BMP-2 and -7 in six cases of CEOT was carried out. Results revealed positive BMP expression and distribution patterns suggesting that these protein molecules most likely participate in the process of cellular proliferation and differentiation in this neoplasm. The strong BMP-7 expression in CEOT-associated amyloid-like substances is a novel finding.
